- 25 de setembro de 2014
- Posted by: Assessoria Imprensa
- Category: Resoluções
(Dispõe sobre as medidas de controle de comercialização, prescrição e dispensação de medicamentos que contenham as substâncias anfepramona, femproporex, mazindol e sibutramina, seus sais e isômeros, bem como intermediários e dá outras providências).
Confira documento publicado na íntegra pela ANVISA
Wow, that’s what I wass looking for, what a stuff! pressnt
here at this webpage,thanks admin off this web site.
Good post. I learn something totally new and challenging on sites I stumbleupon every day.
It’s always useful too reead articles from ofher writers annd practicce a little something from tgeir websites.
magnificent issues altogether, you just gained a emblem neew
reader. What would you suggest about your pubish tbat you just made a
few days in the past? Any sure?
Undeniably believe thast which you stated. Your favorite reason seemed
to be on the net the eaiest thing to be aware of. I say to you,
I certainly get annoyed while peolle consider worries that they just don’t know about.
You managed to hit the nail upon the ttop as well as defined out the whole thing without having side effect , people could
takee a signal. Wiill likely be back to get more.
Thanks
Everything is very oplen with a very clear clarjfication oof
the issues. It was really informative. Youur site is extremely helpful.
Thanks for sharing!
It’s an remarkable post in favgor of all the web users; they
will take benefit from it I am sure.